...
首页> 外文期刊>Current opinion in anaesthesiology >Management of perioperative heart failure
【24h】

Management of perioperative heart failure

机译:围手术期心力衰竭的处理

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE OF REVIEW: In the perioperative period, acute heart failure can result from a variety of conditions, and treatment may vary considerably depending on its mechanism. This review aims to provide conceptual framework by selectively presenting recent knowledge and advances in acute heart failure therapies including drugs (inotropes, diuretics) and devices (mechanical assistance, biventricular pacing, ultrafiltration). RECENT FINDINGS: The calcium sensitizer levosimendan, showed a mortality benefit in cardiac surgery patients in a recent meta-analysis. A study involving patients with cardiogenic shock complicating myocardial infarction for which early revascularization was planned, intra-aortic balloon support did not reduce 30-day mortality. A novel study showed that ultrafiltration was inferior to pharmacologic therapy in acute heart failure in nonsurgical patients. Biventricular pacing provided a significant clinical benefit over right ventricular pacing in nonsurgical patients with left ventricular dysfunction and atrioventricular block. Two recently published meta-analyses confirmed the prognostic role of natriuretic peptides in the perioperative setting. SUMMARY: Poor data exist in the perioperative setting concerning acute heart failure therapies. Large trials are needed to support the use of levosimendan, mechanical assistance, utrafiltration and biventricular pacing in the perioperative setting. The prognostic role of natriuretic peptides was confirmed in the perioperative period.
机译:审查的目的:在围手术期,急性心力衰竭可以由多种疾病引起,并且根据其机制,治疗方法可能会有很大差异。这篇综述旨在通过选择性介绍急性心力衰竭治疗的最新知识和进展(包括药物(肌力药,利尿剂)和设备(机械辅助,心室起搏,超滤))提供概念框架。最近的发现:在最近的荟萃分析中,钙敏化剂左西孟旦对心脏外科手术患者显示出死亡率方面的益处。一项涉及心源性休克并发心肌梗死并计划进行早期血运重建的患者的研究表明,主动脉内球囊支持不能降低30天死亡率。一项新的研究表明,在非手术患者的急性心力衰竭中,超滤不如药物治疗。对于有左心功能不全和房室传导阻滞的非手术患者,双心室起搏比右心室起搏具有明显的临床意义。最近发表的两项荟萃分析证实了利钠肽在围手术期中的预后作用。摘要:围手术期有关急性心力衰竭治疗的数据很差。在围手术期需要大量试验来支持左西孟旦的使用,机械辅助,超滤和双心室起搏。在围手术期证实了利钠肽的预后作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号